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Members of the Scedosporium apiospermum species complex are the second most
frequently isolated pathogens after Aspergillus fumigatus from cystic fibrosis (CF)
patients with fungal pulmonary infections. Even so, the main risk factors for the infection
are unrevealed. According to previous studies, bacterial infections might reduce the
risk of a fungal infection, but an antibacterial therapy may contribute to the airway
colonization by several fungal pathogens. Furthermore, corticosteroids, which are often
used to reduce lung inflammation in children and adults with CF, are also proved
to enhance the growth of A. fumigatus in vitro. Considering all the above discussed
points, we aimed to test how Pseudomonas aeruginosa influences the growth of
scedosporia and to investigate the potential effect of commonly applied antibacterial
agents and corticosteroids on Scedosporium species. Direct interactions between
fungal and bacterial strains were tested using the disk inhibition method. Indirect
interactions via volatile compounds were investigated by the plate-in-plate method,
while the effect of bacterial media-soluble molecules was tested using a modified
cellophane assay and also in liquid culture media conditioned by P. aeruginosa. To
test the effect of bacterial signal molecules, antibacterial agents and corticosteroids on
the fungal growth, the broth microdilution method was used. We also investigated the
germination ability of Scedosporium conidia in the presence of pyocyanin and diffusible
signal factor by microscopy. According to our results, P. aeruginosa either inhibited
or enhanced the growth of scedosporia depending on the culture conditions and the
mode of interactions. When the two pathogens were cultured physically separately from
each other in the plate-in-plate tests, the presence of the bacteria was able to stimulate
the growth of several fungal isolates. While in direct physical contact, bacterial strains
inhibited the fungal growth. This effect might be attributed to bacterial signal molecules,
which also proved to inhibit the germination and growth of scedosporia. In addition,
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antibacterial agents showed growth-promoting, while corticosteroids exhibited growth
inhibitory effect on several Scedosporium isolates. These data raise the possibility that a
P. aeruginosa infection or a previously administered antibacterial therapy might be able
to increase the chance of a Scedosporium colonization in a CF lung.
Keywords: Scedosporium, Pseudomonas aeruginosa, cystic fibrosis, volatile organic compounds, diffusible
signal factor, pyocyanin, tobramycin, flucloxacillin
INTRODUCTION
Scedosporium species are ubiquitous saprophytic
hyalohyphomycetes present in environments affected and
transformed by anthropogenic activities, such as agricultural
and industrial soils or sewage. Members of the genus
Scedosporium are associated with a wide spectrum of human
infections, including pneumonia, mycetoma, and keratitis
in immunocompetent hosts and systemic invasive diseases
in immunocompromised patients or in near-drowning
victims (Guarro et al., 2006; Cortez et al., 2008). They may
also cause usually fatal central nervous system infections in
both healthy and immunocompromised individuals through
hematogenous spreading from a localized infection or after a
surgery (Kowacs et al., 2004; Tortorano et al., 2014) and are
frequently detected in the sputum of patients with cystic fibrosis
(CF) (Schwarz et al., 2017).
Molecular identification methods and the introduction of
the new nomenclature system for fungi (Hawksworth et al.,
2011) resulted in fundamental changes in the taxonomy
of the related genera Scedosporium and Pseudallescheria.
For instance, the phylogenetically and morphologically
distinct but clinically relevant Scedosporium prolificans has
been reallocated to the genus Lomentospora (Lackner et al.,
2014). Currently, the genus Scedosporium is considered to
comprise 10 species, namely S. aurantiacum, S. cereisporum,
S. dehoogii, S. desertorum, S. minutisporum and the
members of the S. apiospermum species complex, including
S. angustum, S. apiospermum, S. boydii, S. ellipsoideum and
S. fusoideum (Ramirez-Garcia et al., 2018). Out of these species,
S. apiospermum, S. boydii, and S. aurantiacum are regularly,
while S. ellipsoideum and S. minutisporum are sporadically
associated with CF lung infections with a geographically
variable prevalence (Blyth et al., 2010; Zouhair et al., 2013;
Sedlacek et al., 2015). S. angustum is not a common CF
pathogen, but it has been reported from human lung mycetoma
before (Kravitz et al., 2011).
Cystic fibrosis is one of the most common genetic disorders,
that is resulted by the mutation of the gene encoding the
CF transmembrane conductance regulator (CFTR) protein.
Dysfunction of CFTR affects the transepithelial fluid and the
ion transport of the exocrine glands and leads to a nutrient
rich, thick airway surface liquid in the lungs. This highly viscous
mucus cannot be cleared effectively by the muco-ciliary transport
system supporting the colonization of the airways by bacterial
and fungal pathogens (Lightly et al., 2017). Chronic infections
are among the primary causes of mortality of CF patients, since
both the infecting microbes and the inflammation response cause
irreversible damage in the lung tissue and lead to a respiratory
failure (LiPuma, 2010).
Generally, Staphylococcus aureus is the first colonizer of
the CF lung, but by the time the patients reach the
adulthood, P. aeruginosa becomes the most frequently isolated
bacterium causing chronic lung infections (LiPuma, 2010).
Among filamentous fungi, Aspergillus fumigatus (16–58%)
and the S. apiospermum species complex (9–10%) are the
most prevalent pathogens isolated from CF patients (Noni
et al., 2017; Reece et al., 2017). Clinical manifestations and
radiological and histopathological appearance of Scedosporium
may overlap with other hyaline molds (i.e., Aspergillus and
Fusarium spp.) (Rolfe et al., 2013; Ramirez-Garcia et al.,
2018). Moreover, the use of a selective medium would be
advantageous for the reliable culture detection of Scedosporium
spp. in clinical practice since the members of this genus
are easily overgrown by rapidly and extensively growing
fungi (e.g., Aspergillus spp.) giving false negative results on
standard culture media (Pham et al., 2015; Sedlacek et al.,
2015). Therefore, the real incidence of Scedosporium species
in CF might be underestimated. The antifungal susceptibility
profile of scedosporia is reported to substantially differ from
those of other filamentous fungi, such as aspergilli, being less
sensitive to the most commonly used antifungal drugs (Guarro
et al., 2006; Wiederhold and Lewis, 2009). Consequently, the
misdiagnosis of scedosporia might lead to an ineffective therapy
and unexpected complications.
While CF-related therapeutic approaches and research have
mainly focused on one pathogen at a time, it is more commonly
accepted that these infections are associated with dynamically
changing polymicrobial communities (Sibley and Surette, 2011).
In these communities, both pathogens and commensals might
be found. Although the commensal species are mainly harmless,
they might affect the infection through their interactions
with other members of the community (Noni et al., 2017).
The role of scedosporia in the CF-lung microbiota is not
yet completely revealed, but its understanding might help
in the fight against infections and to improve the patients’
medical conditions.
Risk factors for Scedosporium infections in CF patients are
still unrevealed. According to Blyth et al. (2010), Australian
patients colonized with mucoid P. aeruginosa are less frequently
infected with scedosporia. A recent study from Germany
showed quite the contrary reporting a positive correlation
between the co-colonization with mucoid P. aeruginosa and
S. apiospermum complex/L. prolificans (Schwarz et al., 2017).
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Anyway, the co-incidence of Scedosporium species with
mucoid and non-mucoid P. aeruginosa is relatively high,
reported to be 75–88.5% and 50–57.7%, respectively (Blyth
et al., 2010; Schwarz et al., 2017). Blyth et al. (2010) also
reported that antistaphylococcal penicillin therapy may
contribute to the airway colonization by scedosporia.
Similarly, Burns et al. (1999) found significant correlation
between tobramycin therapy and the incidence of Aspergillus
and Candida infections. Interestingly, the volatilome of
P. aeruginosa was reported to act as a growth-enhancer
for aspergilli (Briard et al., 2016), suggesting that a prior
bacterial infection might also favor the invasion of the lung by
filamentous fungi.
In view of the literature described above, our main purpose
was to investigate how P. aeruginosa influences fungal growth by
indirect and direct physical contact with scedosporia. Besides, we
also aimed to test the direct effect of certain antibacterial agents
and corticosteroids on the growth of Scedosporium species.
MATERIALS AND METHODS
Strains and Culture Conditions
Experiments were performed on two Pseudomonas aeruginosa
and ten Scedosporium isolates representing the species
S. angustum, S. apiospermum, S. aurantiacum, S. boydii,
and S. ellipsoideum (Table 1). The two P. aeruginosa strains
were selected based on their phenotypic differences on
lysogeny broth (LB) and their distinct source of isolation.
While the strain ATCC 27853 originated from a blood
specimen and displayed a yellow colony color, the other
strain (ATCC 19429) was derived from a urine sample and
formed a dark greenish-blue colony secreting bluish pigments
(probably the mixture of pyoverdine, pyorubin, and pyocyanin;
Yabuuchi and Ohyama, 1972) in the medium. Since Aspergillus
fumigatus is a relatively well described CF-related pathogen, we
TABLE 1 | Fungal and bacterial strains involved in the study.
Strain no. Species Source
CBS 254.72 Scedosporium angustum Sewage/United States
CBS 117410 Scedosporium boydii Soil/Spain
CBS 117432 Scedosporium boydii CF sputum/France
CBS 120157 Scedosporium boydii Lung, leukemia/France
CBS 301.79 Scedosporium ellipsoideum Dung of
cow/Netherlands
CBS 116910 Scedosporium aurantiacum Wound exudate, ulcer
of ankle/Spain
CBS 136046 Scedosporium aurantiacum Invasive human lung
infection/Australia
CBS 136047 Scedosporium aurantiacum Soil/Australia
CBS 136049 Scedosporium aurantiacum Soil/Austria
SZMC 23374 Scedosporium apiospermum Mycetoma/Hungary
SZMC 23245 Aspergillus fumigatus Keratitis/Croatia
ATCC 27853 Pseudomonas aeruginosa Blood
culture/United States
ATCC 19429 Pseudomonas aeruginosa Urine
included its clinical isolate SZMC 23245 in all experiments as a
reference strain.
LB medium (Table 2) was used to culture the bacteria at 37◦C
for 24 h, while fungal strains were grown on malt-extract agar
(MEA, Table 2) at 37◦C for 7 days. Both bacterial cells and
fungal conidia were harvested freshly before each experiment
in saline solution (0.85% NaCl solution supplemented with
0.01% Tween 80). Cell and conidia densities were determined
using a Bürker-chamber and the final inoculum densities were
set to 105 CFU/ml for the bacterial and 104 CFU/ml for the
fungal isolates.
Pseudomonas aeruginosa Cell Fractions
Heat killed and lysed bacterial cells and bacterial culture
supernatants were prepared according to Pethani (2015) with
slight modifications. In order to prepare heat killed cells, 1 ml
of the 48 h culture of P. aeruginosa (0.5 × 109 – 1.0 × 109
CFU/ml) was heat treated at 80◦C for 60 min. Ten microliters
of the cultures were plated on solid LB medium and incubated
overnight at 37◦C to check the efficiency of the treatment.
Cell culture supernatants were collected by centrifuging 1 ml
of the 48 h cultures (0.5 × 109 – 1.0 × 109 CFU/ml) of
P. aeruginosa strains at 10,000 × g for 30 min. The obtained
supernatants were filtered through a 0.22 µm syringe filter.
To prepare cell lysates, the remaining pellet was resuspended
in 1 ml distilled water, chilled at −20◦C, then sonicated for
30 min in an ultrasonic processor. The sonicated suspensions
were centrifuged at 10,000 × g for 30 min to remove the
cellular debris and the supernatant was filtered through a syringe
filter with a pore size of 0.22 µm to remove the remaining
cellular particles.
Direct Interactions
Direct interactions between living fungal and bacterial strains
were tested on synthetic cystic fibrosis medium (SCFM,
Kozlowska et al., 2013) and on RPMI-1640 agar using the
disk inhibition method. The compositions of these media are
listed in Table 2. Firstly, the inhibitory effect of the fungal
strains was tested against the bacteria. 100 µl of 104 CFU/ml
conidial suspensions were spread on the plates. After drying,
sterile filter paper disks with a diameter of 0.8 mm were
placed at the center of each plate and inoculated with 10 µl of
5 × 105 CFU/ml P. aeruginosa suspension. As a control, the
same amounts of bacterial cells were grown on sterile media.
As an inverse of this test, inhibitory activity of the bacterial
strains on the fungal growth was tested as follows: 100 µl of
105 CFU/ml P. aeruginosa suspensions were spread onto the
plates and 10 µl of 104 CFU/ml conidial suspensions were added
to the filter paper disks. The control plates were free of the
P. aeruginosa cells. Inhibition percentages were calculated at 3
days post inoculation (dpi) by comparing the diameter of the
central colonies grown on the co-culture plates to the control
ones growing in mono-culture.
The effects of heat killed and lysed bacterial cells and bacterial
culture supernatants on fungal growth were tested similarly
by adding 10 or 50 µl of each cell fraction on the filter
paper disk instead of a living cell suspension. All plates were
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TABLE 2 | The list and composition of the media used in the study.
Media Components
LB 1% NaCl, 1% peptone, 0.5% yeast extract (supplemented with 2% agar in case of solid media)
MEA 5% malt extract, 1% glucose, 2% agar
SCFM (Kozlowska et al., 2013) Basic components (autoclaved): 0.65% 0.2 M NaH2PO4; 0.625% 0.2 M Na2HPO4; 0.035% 1 M KNO3; 1% 119 mM
diethylene triamine pentaacetic (Sigma-Aldrich); 1% porcine gastric mucin (Sigma-Aldrich), 0.14% herring sperm DNA
(Sigma-Aldrich), 0.2% MOPS (PanReac AppliChem), 0.3% NaCl; 0.012% NH4Cl; 0.1% KCl; 2% agar, pH 6.8.
Additional components (filter sterilized with a syringe filter [0.22 µM, Merck]): 0.5% egg yolk emulsion (Sigma-Aldrich);
1% BSA (bovine serum albumin, VWR); 0.06% 1M MgCl2; 0.1% 3.6 mM FeSO4 × 7H2O; 0.175% 1 M CaCl2; 1–1%
amino acid stock solutions I–VIII.
Stock solutions of amino acids (AA) (pre-prepared, filter-sterilized and stored at 4◦C until use):
AA solution I: 53 mM L-phenylalanine, 212.8 mM L-lysine × HCl, 30.6 mM L-arginine × HCl.
AA solution II: 120.3 mM L-glycine, 111.7 mM L-valine, 178 mM L-alanine, 1.3 mM L-tryptophan.
AA solution III: 107.2 mM L-threonine, 144.6 mM L-serine, 166.1 mM L-proline.
AA solution IV: 82.7 mM L-aspartate, 16 mM L-cysteine × HCl, 9.1% (v/v) 36.5% HCl.
AA solution V: 154.9 mM L-glutamate × HCl, 80.2 mM L-tyrosine, 4% NaOH.
AA solution VI: 160.9 mM L-leucine.
AA solution VII: 67.6 mM L-ornithine × HCl, 63.3 mM L-methionine, 51.9 mM L-histidine × HCl.
AA solution VIII: 112 mM L-isoleucine.
RPMI-1640 RPMI-1640 medium (Sigma-Aldrich) buffered with 0.165 M MOPS and supplemented with 0.03% L-glutamine
RPMI-1640 agar RPMI-1640 supplemented 2% agar
MM 2.5% agar; 0.05% MgSO4; 0.05% KCl; 0.05% K2HPO4; 0.001% ZnSO4; 0.001% FeSO4; 0.0003% CuSO4, 0.3%
NaNO3, 3% sucrose.
Carbon-depleted MM MM without sucrose.
Nitrogen-depleted MM MM without NaNO3.
Sulfur-depleted MM 2.5% agar; 0.05% MgCl2; 0.05% KCl; 0.05% K2HPO4; 0.001% ZnCl2, 0.001% FeCl3, 0.0003% CuCl2; 0.3% NaNO3;
3% sucrose.
Carbon- and nitrogen-depleted MM MM without sucrose and NaNO3.
Carbon- and sulfur-depleted MM Sulfur-depleted MM without sucrose.
Nitrogen- and sulfur-depleted MM Sulfur-depleted MM without NaNO3.
Carbon-, nitrogen- and sulfur-depleted MM Sulfur-depleted MM without sucrose and NaNO3.
LB, lysogeny broth; MEA, malt extract agar; MM, minimal medium; RPMI, Roswell Park Memorial Institute; SCFM, synthetic cystic fibrosis medium.
incubated at 37◦C for 3 days and the diameter of the inhibition
zone was measured.
Indirect Interactions via Volatile Organic
Compounds (VOCs)
To examine indirect interactions via VOCs between fungi and
bacteria, the so-called “plate-in-plate” method was used (Briard
et al., 2016). This approach allows to grow bacteria and fungi in
the same atmosphere but on different culture media, physically
separately from each other.
In these experiments, 10 µl of 104 CFU/ml fungal conidial
suspensions were inoculated at the center of the inner plate,
while 100 µl of 105 CFU/ml bacterial suspensions were spread
on the outer plate. Petri dishes were sealed with parafilm and
placed in self lock plastic bags to prevent the VOCs from escaping
into the incubator. After 7 days of incubation, the diameter of
the fungal colonies was measured. Then, the entire colony was
scraped carefully from the surface of the media using a sterile
scalpel and dried in an oven at 70◦C for 16 h to determine their
dry weight. Lastly, biomass density (BD) values were calculated
using the following formula of Reeslev and Kjoller (1995):
BD = dry weight (mg)/area of the colony (cm2).
We started these experiments using nutrient rich media, such
as RPMI-1640 agar and SCFM, for the cultivation of bacteria
and fungi, as well. In the next eight experimental conditions,
bacteria were grown uniformly on solid LB media to provide
a stable environment for them through the tests and only the
contents of the inner plate were changed. Based on the work
of Briard et al. (2016) and the facts that VOCs are all carbon-
based molecules and P. aeruginosa is able to produce both sulfur-
and nitrogen-containing molecules along with a large variety of
volatile metabolites (Bos et al., 2013), fungal isolates were grown
on various nutrient-depleted media, i.e., minimal medium (MM),
carbon-depleted MM, nitrogen- depleted MM, sulfur-depleted
MM, and their combinations carbon- and nitrogen-depleted
MM, carbon- and sulfur-depleted MM, nitrogen- and sulfur-
depleted MM and finally carbon-, nitrogen- and sulfur-depleted
MM. Compositions of these media are detailed in Table 2.
Indirect Interactions via Media-Soluble
Molecules
Indirect interactions via media-soluble molecules were
investigated by the modified cellophane assay of Heatley (1947)
on solid SCFM and RPMI-1640 media and by culturing the fungi
in liquid RPMI-1640 conditioned by P. aeruginosa strains.
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For the cellophane assay, the surface of the media was covered
with a sterile cellophane sheet with the shape and size of a 90 mm
Petri dish. Then a sterile filter paper disk with a diameter of
0.8 mm was placed at the center of the plate and inoculated with
10 µl of 5× 105 CFU/ml P. aeruginosa suspension, except for the
control plates, which were inoculated with sterile distilled water.
All the plates were incubated at 37◦C. Before the cellophane
membranes were uncovered from the plates along with the
bacterial colonies at 2 dpi, colony diameters of P. aeruginosa
were determined in two perpendicular directions. Then 100 µl
of 2 × 104 CFU/ml conidial suspensions were spread on the
underlying medium. The diameters of inhibition zones indicating
the penetration of bacterial small diffusible molecules through
the cellophane membrane were determined after 3 days of
incubation at 37◦C. The area of colonies and inhibition zones
were determined using the formula pi × a × b, where “a” and
“b” were the two radii measured in two perpendicular directions.
Finally, to calculate the relative inhibition activity (RIA) of the
bacteria, the area of each inhibition zone detected for the fungal
colonies was divided by the area of the related bacterial colony.
To prepare conditioned media, 1-day-old cultures of
P. aeruginosa strains grown in LB media were diluted to a density
of 1× 105 CFU/ml in saline solution. Then, 10 ml of RPMI-1640
was inoculated with 100 µl of the diluted bacterial suspensions
to reach the final density of 103 CFU/ml and incubated at 37◦C
without shaking. Medium used for the growth control wells
was inoculated with 100 µl of sterile saline solution and kept at
37◦C, as well. At 2 dpi, both infected (containing 1.0 × 108 –
5.0 × 108 CFU/ml) and non-infected media were centrifuged
at 4,000 rpm for 10 min at 15◦C and the supernatants were
filtered through a 0.45 µm and subsequently a 0.22 µm syringe
filter (Merck). Then, pH of the conditioned and the control
media were measured in order to confirm that bacteria do not
affect the fungal growth by altering the neutrality of the media.
The effect of the obtained sterile bacterial supernatants on the
growth of filamentous fungal isolates was tested in 96-well
microplates. One hundred microliters of the supernatant was
mixed in each well with 100 µl conidial suspensions diluted in
RPMI-1640 to a density of 2 × 104 CFU/ml. Growth control
wells contained 100 µl of uninfected but centrifuged and filter-
sterilized RPMI-1640 mixed with 100 µl conidial suspensions.
Sterile controls contained 200 µl treated and untreated media
without conidia. Fungal growth was evaluated after 24, 48, and
72 h of incubation at 37◦C by measuring the optical density
of each sample at 620 nm with an absorbance plate reader
(SPECTROstar Nano, BMG Labtech). The absorbances of the
untreated control cultures were referred to 100% of growth in
each case. Experiments were performed in three independent
experiments with three individual replicates.
In vitro Effect of Bacterial Signal
Molecules, Antibacterial Agents, and
Corticosteroids on Scedosporia
Two commercially available bacterial signal molecules, pyocyanin
(Sigma-Aldrich) and diffusible signal factor (DSF; cis-11-
methyl-2-dodecenoic acid; Sigma-Aldrich), three commonly
used antibacterial agents (i.e., tobramycin, ceftazidime and
flucloxacillin; Sigma-Aldrich) and three corticosteroids (i.e.,
hydrocortisone, prednisone, and methylprednisolone; Sigma-
Aldrich) were tested in this experiment. The long-term (24–
72 h) effect of these compounds were tested on all the 11
isolates by comparing the absorbance of the treated and non-
treated samples using a plate reader as it was described in the
previous subsection. Additionally, the short-term (2–8 h) effect
of DSF and pyocyanin was also determined by investigating
the germination ability of fungal conidia in the presence of
these compounds under a light microscope: 20 fields of view
(at least 100 conidia) were selected randomly from each sample
where germinated and non-germinated conidia were counted.
In these test, one representative clinical isolate was involved for
each species, namely, S. angustum CBS 254.72, S. boydii CBS
117432, S. ellipsoideum CBS 301.79, S. aurantiacum CBS 136046,
S. apiospermum SZMC 23374 and A. fumigatus SZMC 23245.
Experiments were performed in three independent experiments
with three individual replicates.
The test concentrations of each compound were selected based
on the related literature. Where the reported (plasma and/or
sputum) levels of a compound proved to be highly variable,
the effect of more than one concentration was examined in
the growth experiments. Accordingly, 12.5, 10, and 50 µg/ml
of pyocyanin (Wilson et al., 1988), 50 µg/ml of DSF (Wang
et al., 2004), 10 µg/ml flucloxacillin (Sutherland et al., 1970;
Bodey et al., 1972), 10, 20, and 80 µg/ml of ceftazidime
(Vinks et al., 1997; Moriarty et al., 2007; Hubert et al., 2009),
5, 10, and 20 µg/ml of tobramycin (Moriarty et al., 2007;
VandenBussche and Homnick, 2012), 10−6 M (∼0.36 µg/ml) of
corticosteroids (Ng et al., 1994) were used in these experiments.
While the germination studies were conducted using the highest
abovementioned values (50 µg/ml) of DSF and pyocyanin.
Statistical Analyses
All statistical analyses were performed using GraphPad Prism
6 software. Unpaired t-test was used to reveal significant
differences between the investigated groups. P-values< 0.05 were
considered as statistically significant.
RESULTS
Pseudomonas aeruginosa and
Scedosporium Strains Exert a
Contact-Dependent Inhibitory Effect on
Each Other
Interactions between living bacterial and fungal cells were
investigated using the disk inhibition test. These experiments
revealed medium-specific interactions between the investigated
microorganisms (Figure 1). On RPMI-1640 agar, the fungal
strains acted similarly on P. aeruginosa having an approximately
60% inhibitory effect on both strains (Figures 1A,B, left).
In the reverse case, both bacterial strains showed an equally
strong inhibitory action (100%) on all the tested fungal isolates
(Figures 1C,D, left). In comparison, on SCFM, scedosporia
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FIGURE 1 | Direct interactions between Pseudomonas aeruginosa and Scedosporium strains tested by the disk inhibition method. In panel (A), the graphs
represent the mean inhibition percentages of the fungal isolates against P. aeruginosa ATCC 27853 and ATCC 19429 on RPMI-1640 agar (left) and on SCFM plates
(right). Error bars indicate standard deviations. Panel (B) is a representative figure of the plates after 3 days of co-incubation illustrating the direct inhibitory effect of
S. aurantiacum CBS 116910 on the growth of P. aeruginosa ATCC 27853 and ATCC 19429 exerted on RPMI-1640 agar (left) and SCFM plates (right). In panel (C),
the graphs represent the mean inhibition percentages of P. aeruginosa ATCC 27853 and ATCC 19429 against all fungal isolates on RPMI-1640 agar (left) and SCFM
plates (right). Error bars indicate standard deviations. Panel (D) is a representative figure of the plates after 3 days of co-incubation illustrating the direct inhibitory
effect of P. aeruginosa ATCC 27853 and ATCC 19429 on the growth of S. aurantiacum CBS 116910 on RPMI-1640 agar (left) and SCFM plates (right). Arrows
indicate the borders of the colonies in case they are hardly visible.
had a stronger inhibitory effect on P. aeruginosa ATCC 19429
(mean inhibitory percentage: 65.1± 7.4%) than on P. aeruginosa
ATCC 27853 (mean inhibitory percentage: 47.7 ± 20.0%)
(Figures 1A,B, right). Accordingly, P. aeruginosa ATCC 19429
had a less prominent antifungal effect on Scedosporium spp. than
P. aeruginosa ATCC 27853 (Figures 1C,D, right). Additionally,
on SCFM plates, both bacterial strains caused a less prominent
inhibition of the four S. aurantiacum strains (ATCC 27853:
10.1 ± 7.3%; ATCC 19429: 42.1 ± 3.5%) than the other fungal
species (ATCC 27853: 38.9± 15.2%; ATCC 19429: 79.5± 14.2%)
(Figure 1C, right). Prominent differences were not observed
among the bacterial growth inhibitory effect of the fungal
strains (Figure 1A).
Interaction tests with living fungal and heat-killed bacterial
cells were also performed. According to our results, only living
bacterial cells were able to inhibit the fungal growth, and heat
killed cells had no visible effect on the growth of scedosporia
(data not shown).
Bacterial Media-Soluble Molecules
Possess Fungal Growth Inhibitory
Activity
The effect of bacterial diffusible molecules on fungal growth
was tested on solid and in liquid culture media, as well.
P. aeruginosa ATCC 27853 showed stronger indirect inhibitory
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effect in these tests than ATCC 19429 irrespectively to the
type of media (solid or liquid) used. On solid RPMI-1640
plates, mainly complete inhibition zones, while on SCFM, only
partial inhibition zones were observed at the former sites of
the bacterial colonies (Figure 2A and Supplementary Table 1S).
Similarly, in liquid RPMI-1640, the growth of the fungal isolates
was unambiguously higher in the control samples, than in the
medium conditioned by P. aeruginosa ATCC 27853. However,
this antifungal activity decreased over time and was hardly
detectable in case of the medium conditioned by P. aeruginosa
ATCC 19429 (Figure 2B and Supplementary Figure 1S). All data
obtained in the cellophane assay and the microdilution tests with
conditioned media are available in the Supplementary Table 1S
and Supplementary Figure 1S. According to our measurements,
the pH of media conditioned by P. aeruginosa ATCC 27853 and
ATCC 19429 were between 6.94 and 7.05, while that of the control
media was in the range of 6.98–7.05. These results confirmed that
P. aeruginosa did not affect the fungal growth through altering
the pH of the media.
Effect of the bacterial culture supernatant and the cell lysate
was also tested on solid RPMI-1640 and SCFM plates but none
of them showed any visible fungal growth inhibitory effect in the
disk inhibition tests (data not shown).
Bacterial Signal Molecules Affect the
Germination Ability and the Growth Rate
of Scedosporia
The observed indirect antifungal activity of P. aeruginosa might
be attributed to bacterial signal molecules. In order to examine
this hypothesis, the effect of two known signal molecules, namely
DSF and pyocyanin were tested on the germination and growth
rate of scedosporia. These compounds were chosen based on their
previously reported role in inter-kingdom interactions (Boon
et al., 2008; Briard et al., 2015). Figure 3 illustrates our main
findings on the clinical strain S. aurantiacum CBS 136046, the
remaining results of the tests are available in Supplementary
Figures 2S–5S. As a short-term effect, both DSF and pyocyanin
were able to decrease the germination rate of scedosporia
(Figure 3, left panel). Their long-term effect proved to be similar:
the growth rate of fungi significantly decreased in the presence of
these compounds after 24, 48, and 72 h of incubation (Figure 3,
right panel). However, 50 µg/ml of DSF had a more prominent
inhibitory effect on the germ tube formation and elongation than
the same level of pyocyanin.
Pseudomonal Nitrogen- and
Sulfur-Containing VOCs Stimulate the
Growth of Scedosporium spp.
The impact of bacterial VOCs on fungal growth were tested in
plate-in-plates tests. Although the two pathogens were cultured
physically separately from each other in these tests, the presence
of bacteria could stimulate the growth of the fungi (Figure 4).
This trend proved to be statistically significant for S. angustum
CBS 254.72 and A. fumigatus SZMC 23245 isolates on RPMI-agar,
and for S. angustum CBS 254.72 and S. boydii CBS 117410 strains
on SCFM plates (Supplementary Figures 6S, 7S). Interestingly,
the growth of A. fumigatus was not enhanced, but impaired by the
VOCs of P. aeruginosa on SCFM (Figure 4A and Supplementary
Figure 6S), suggesting that these interactions are not just strain-
and species-dependent, but are also affected by the nutrients
(un)available in the environment. It is also noteworthy that
the biomass of Scedosporium spp. was lower on RPMI-1640
agar (median biomass density: 0.13 mg/cm2) than on SCFM
plates (median biomass density: 0.5 mg/cm2) and, except for
the abovementioned two cases, bacterial VOCs had no effect on
fungal growth on this medium, at all.
FIGURE 2 | Bacterial media-soluble/diffusible molecules inhibit the growth of filamentous fungi both on solid (A) and in liquid (B) media. Panel (A) is a representative
figure showing the influence of the bacterial diffusible molecules on the fungal lawn of S. apiospermum SZMC 23374 grown on RPMI-1640 and SCFM plates.
Arrows indicate the borders of the bacterial colony determined in two perpendicular directions. In panel (B), the graphs show the fungal growth rates in the presence
of bacterial diffusible molecules in liquid culture media. Results are the mean from three independent experiments involving three individual replicates. Error bars
indicate standard deviations. P-values were calculated using the unpaired t-test, where p < 0.05 was considered to be significant (indicated with asterisks). Graphs
illustrating the growth rate of the other fungal strains tested are available in Supplementary Figure 1S.
Frontiers in Microbiology | www.frontiersin.org 7 March 2019 | Volume 10 | Article 441
fmicb-10-00441 March 4, 2019 Time: 17:6 # 8
Homa et al. Inter-Kingdom Interactions Between CF Pathogens
FIGURE 3 | Diffusible signal factor (DSF) and pyocyanin (PYO) shows growth inhibitory effect against S. aurantiacum. Panel (A) shows the germ tube formation and
elongation of S. aurantiacum CBS 136046 conidia after 8 h of co-incubation with 50 µg/ml of DSF or pyocyanin and in the control, DSF- and pyocyanin-free
medium. Scale bar = 50 µm. Panel (B) shows the germination (left panel) and the growth rates (right panel) of S. aurantiacum CBS 136046 monitored over the
indicated time course via microscopic and spectrophotometric analyses, respectively. The graphs show mean values with error bars indicating the standard
deviations of three independent experiments. P-values were calculated using the unpaired t-test where p < 0.05 was considered to be significant (indicated with
asterisks). Graphs illustrating the germination and growth rate of the other fungal strains tested are available in the Supplementary Figures 2S–5S.
To make a proposal for the groups of the volatiles responsible
for these effects, fungal isolates were cultured on various
nutrient-depleted media. On nitrogen-depleted MM, fungal
growth proved to be very weak, the biomass densities of
Scedosporium spp. ranged between 0.02 and 0.13 mg/cm2, with
a median value of 0.03 mg/cm2. However, the presence of
the bacteria enabled the growth of all Scedosporium isolates
(median biomass density: 2.2 mg/cm2; biomass density range:
2.18–5.44 mg/cm2) with the exception of the S. aurantiacum
strains (Figure 4C and Supplementary Figure 8S). On the sulfur-
depleted medium, a similar scenario was observed; the four
S. aurantiacum strains were not able to grow, even in the presence
of the P. aeruginosa strains (biomass density ≤ 0.05 mg/cm2).
While, the biomass densities of the S. angustum, S. boydii,
S. ellipsoideum, and S. apiospermum strains were elevated
(median: 2.15 mg/cm2; range: 1.65–6.36 mg/cm2) in the presence
of the bacteria, compared to the bacterium-free, control plates
(median: 0.26 mg/cm2; range: 0.1–1.51 mg/cm2) (Figure 4B and
Supplementary Figure 9S). Similar results were obtained on
nitrogen- and sulfur-depleted MM and also on MM containing
only inorganic salts and sucrose (Supplementary Figures 10S,
11S). Contrastingly, without any carbon source in the medium
all the isolates grew sparsely (biomass density < 0.05 mg/cm2)
and even the presence of bacteria could not stimulate their
growth significantly (Supplementary Figure 13S). In case of
carbon- and nitrogen-depletion, only the growth of A. fumigatus
was enhanced significantly by the presence of the Pseudomonas
strains (Supplementary Figure 12S). Under simultaneous
carbon and sulfur starvation, the presence of the bacteria
had neither negative, nor positive impact on the growth of
fungal isolates (Supplementary Figure 14S). Finally, on carbon-,
nitrogen-, and sulfur-depleted MM, the strain P. aeruginosa
ATCC 192429 had a significant growth inhibitory effect on
two S. boydii and two S. aurantiacum isolates, whereas the
biomass of A. fumigatus proved to be significantly increased
in its presence (Supplementary Figure 15S). In summary, the
significant growth-promoting effect P. aeruginosa was detected
on nitrogen- and/or sulfur-depleted MM, suggesting that volatile
nitrogen- and sulfur-containing compounds might be in the
background of the growth stimulating effect.
The graphs on Figures 4B,C also shows that the
representatives of S. aurantiacum – unlike S. boydii or
S. apiospermum isolates – were not able to utilize the bacterial
nitrogen- and sulfur-containing VOCs from the air, but required
these chemical elements fixed in the media for their growth. This
observation suggests some fundamental differences between the
nitrogen and sulfur metabolism of S. aurantiacum and the other
tested Scedosporium species and even A. fumigatus.
In vitro Effect of Corticosteroids and
Antibacterial Agents on Scedosporia
In order to examine the possible side effects of a corticosteroid
therapy in CF patients, the effect of pharmacologically relevant
concentration of corticosteroids was investigated on the growth
of scedosporia. According to our results summarized in Figure 5
and Supplementary Figure 16S, the growth rate of the isolates
remained generally unaffected by the presence of 10−6 M
hydrocortisone. Although a small, but significant decrease was
observed in case of the S. angustum and an S. boydii isolate.
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FIGURE 4 | Representative results of the plate-in-plate (PIP) co-culture tests. The impact of bacterial VOCs on the growth of certain Scedosporium strains and
A. fumigatus after 7 days of co-incubation at 37◦C on SCFM (A, left panel), on S-depleted MM (B, left panel) and on N-depleted MM; (C, left panel) are
presented. P-values were calculated using the unpaired t-test, where p < 0.05 was considered as significant (indicated with asterisks). Graphs illustrating biomass
densities of the other fungal strains and the results obtained on the other eight culture media are available in the Supplementary Figures 6S–15S. The right panels
demonstrate the growth of A. fumigatus SZMC 23245 on SCFM (A, right panel) and S. apiospermum SZMC 23374 cultured on S- (B, right panel) and on
N-depleted MM (C, right panel) in the presence or absence of bacteria.
Furthermore, after 24 h of co-incubation with prednisone and
methylprednisolone the growth of the vast majority of isolates
proved to be lower compared to the steroid-free samples.
In contrast, these compounds showed a significant growth
promoting effect on A. fumigatus at the 48th hour of incubation.
Clinical studies showed that a prior antibacterial therapy (i.e.,
flucloxacillin and tobramycin) may increase the risk of fungal
colonization and infections in CF (Burns et al., 1999; Blyth
et al., 2010). To test the background of this phenomenon, the
direct effect of three antibiotics usually taken by CF patients
were tested against scedosporia (Hubert et al., 2009; Blyth
et al., 2010; VandenBussche and Homnick, 2012). We observed
that the presence of tobramycin in the culture media was
able to increase the growth rate of the isolates (Figure 5
and Supplementary Figure 17S). These differences proved
to be statistically significant when 10 µg/ml of tobramycin
was applied, but interestingly neither 5 nor 20 µg/ml of the
drug caused a similar prominent effect. In the presence of
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FIGURE 5 | Direct fungal growth influencing effect of antibacterial agents and corticosteroids. Growth rate of Scedosporium boydii CBS 117410 and
S. apiospermum SZMC 23374 in the presence of (A) 10−6 M (∼0.36 µg/ml) corticosteroid compounds (i.e., hydrocortisone, HC; prednisone, PDN and
methylprednisolone, MPS), (B) ceftazidime (CAZ), (C) flucloxacillin (FLX) and (D) tobramycin (TOB). Results are the mean of three independent experiments with
three individual replicates. Error bars indicate standard deviations. P-values were calculated using unpaired t-test, where p < 0.05 was considered to be significant
(indicated with asterisks).
10 and 20 µg/ml ceftazidime, Scedosporium and A. fumigatus
isolates showed decreased growth properties (Figure 5 and
Supplementary Figure 18S). When exposed to 80 µg/ml of
the same antibacterial agent, the growth of fungi proved to
be highly variable compared to the control samples. Finally,
flucloxacillin influenced positively the growth of S. boydii,
S. ellipsoideum and A. fumigatus isolates after 48 and/or 72 h
of incubation, but it caused a significantly decreased growth
in S. angustum after the first day of incubation (Figure 5 and
Supplementary Figure 19S).
DISCUSSION
This comprehensive study focused on the in vitro interactions of
P. aeruginosa and Scedosporium strains. The direct influence of
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commonly used antibacterial agents and corticosteroids on the
growth of Scedosporium spp. was investigated, as well.
Pseudomonas aeruginosa and
Scedosporium Strains Exert a
Contact-Dependent Inhibitory Effect on
Each Other
In agreement with our data, the antifungal activity of
P. aeruginosa was confirmed on solid media in direct contact
with S. aurantiacum by Kaur et al. (2015), Pethani (2015), and
Chen et al. (2018), too. These studies also proved that heat killed
cells caused no visible fungal growth inhibition indicating the
necessity of living P. aeruginosa cells to inhibit the growth of
Scedosporium species (Pethani, 2015). According to Kaur et al.
(2015) inhibition pathways might only be induced in bacterial-
fungal co-cultures. In addition to these studies, our results
suggest that in direct physical contact not just P. aeruginosa was
able to inhibit the growth of Scedosporium spp., but these fungi
were also capable to inhibit the bacterial growth. In contrast to
this observation, conidia and cell fractions of S. aurantiacum
failed to display any inhibition against P. aeruginosa previously
(Kaur et al., 2015), which may be explained by the distinct
experimental approach applied in this study. Similarly to us,
Reece et al. (2018) observed a mutually antagonistic relationship
between P. aeruginosa and A. fumigatus. This study identified
gliotoxin as the main inhibitory agent of bacterial growth in the
culture supernatant of A. fumigatus (Reece et al., 2018). To our
knowledge, toxins have not been described from Scedosporium
species before. Therefore, the background of their antagonistic
effect against bacteria is yet to be investigated in the future.
Bacterial Media-Soluble Molecules
Possess Fungal Growth Inhibitory
Activity
The results of the cellophane assay and the broth microdilution
tests revealed that bacterial diffusible molecules might have
fungal growth inhibitory effect on Scedosporium spp. Whereas,
10 or 50 µl of the bacterial cell culture supernatants had no
effect in the disk inhibition assay. Prior to the present study,
100 µl of culture supernatants and cell lysates of P. aeruginosa
were reported to possess inhibitory action on S. aurantiacum
strains in agar diffusion tests (Pethani, 2015). Although, this
seems to contrast with our results, it should be noted that,
similarly to us, Pethani (2015) observed that 10 µl of the
bacterial culture supernatant or the cell lysate did not cause
fungal growth inhibition. This concentration dependent action
of the bacterial supernatant is also supported by the fact that
it caused significant inhibition in the microdilution tests where
fungal conidia and the bacterial cell culture supernatant were
mixed in a 1:1 ratio. Similarly, in the cellophane assay where the
media under the bacterial colony might be corresponded with
a bacterial culture supernatant, both bacterial strains were able
to affect the growth of Scedosporium spp. causing complete or
partial inhibition zones.
Besides, Pethani (2015) observed that environmental
S. aurantiacum strains were more susceptible to bacterial
supernatants than the clinical strains. We did not observe this
phenomenon neither among S. aurantiacum, nor among the
other Scedosporium strains tested. According to Mowat et al.
(2010) extracellular, soluble and heat-stable factors might be
in the background of the fungal growth inhibitory effect of the
supernatant of P. aeruginosa. As it was previously reported,
soluble metabolites are often responsible for short distance
interactions (Tyc et al., 2017), which is in line with our findings,
that inhibition zones did not exceed the boundaries of bacterial
colonies in the cellophane assay.
DSF and Pyocyanin Affect the
Germination Ability and the Growth Rate
of Scedosporia
According to the literature, the observed direct and indirect
inhibitory effect of P. aeruginosa might be attributed to DSF
family members and phenazines, e.g., pyocyanin (Wang et al.,
2004; Boon et al., 2008; Briard et al., 2015). The DSF family
includes structurally related, bacterial quorum sensing signal
molecules, to be more precise, cis-2-unsaturated fatty acids of
different chain length and branching patterns. These factors
play an important role in virulence by regulating biofilm
formation, antibiotic tolerance and might be involved in
interspecies interactions (Jennings et al., 2012; Ryan et al., 2015).
Additionally, in vivo studies revealed that DSF promoted the
persistence of P. aeruginosa in the infected lung of CF mice
and enhanced the antibacterial resistance of bacterial biofilms
(Twomey et al., 2012). Furthermore, these compounds play a role
in inter-kingdom interactions, too. DSF family molecules proved
to inhibit the morphological transition in Candida albicans,
however, with a varying efficiency (Boon et al., 2008). In DSF-free
medium, more than 50% of the yeast cells germinated, in contrast
to this, both 50 and 5 µg/ml of DSF decreased this number under
10% (Wang et al., 2004). Our findings confirmed these results in
Scedosporium and Aspergillus isolates, we observed a significant
decrease in their germination and growth rate in the presence of
50 µg/ml of DSF (Figure 3 and Supplementary Figures 3S, 4S).
Pyocyanin is a redox-active, blue colored phenazine pigment
produced by P. aeruginosa under quorum sensing regulation. It is
a major virulence factor of the species, which helps the pathogen
in the adaptation to the host environment and causes a wide array
of damages in the infected host cells (Denning et al., 1998; Usher
et al., 2002; O’Malley et al., 2003, 2004; Winstanley and Fothergill,
2009). Pyocyanin may also mediate antagonistic interaction
between P. aeruginosa and its bacterial or fungal competitors
(e.g., C. albicans, Aspergillus spp.; Kerr et al., 1999). However,
this effect is thought to be restricted to aerobic conditions, unlike
the CF lung, which is commonly described as an oxygen-limited
environment (Winstanley and Fothergill, 2009). According to
Briard et al. (2015), phenazines of P. aeruginosa exerts their
antifungal effect by inducing reactive oxygen and nitrogen species
apart from 1-hydroxyphenazine, which acts as an iron chelator
and induces iron starvation in fungi. This study also showed,
that the sub-inhibitory concentrations of pyocyanin, phenazine-
1-carboxamide and phenazine-1-carboxylic acid had growth-
promoting effect on A. fumigatus, by reducing Fe(III) to the more
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soluble Fe(II), which is taken up by the fungus. In summary,
phenazines possess a dose-dependent, dual effect on fungi,
enabling finely regulated interactions between P. aeruginosa and
A. fumigatus. The minimum inhibitory concentration (MIC) of
pyocyanin against A. fumigatus was 2 mM (∼400 µg/ml; Briard
et al., 2015). While in two additional studies, the MIC values
ranged between 40 and 128 µg/ml against Candida spp. and
Cryptococcus neoformans and proved to be 64 µg/ml against
A. fumigatus and A. flavus isolates (Sudhakar and Karpagam,
2011; Sudhakar et al., 2013). In the present study, we focused on
the previously measured peak levels of pyocyanin in the sputum
(Wilson et al., 1988), which are generally lower than the MICs
determined by previous reports. Thus, as it was expected based on
the abovementioned studies, the ≤50 µg/ml levels of pyocyanin
could not cause complete growth inhibition in Scedosporium
and A. fumigatus isolates, but significantly decreased their
growth rates in almost every case (Figure 3 and Supplementary
Figures 5S, 6S). In contrast to this, Kaur et al. (2015) observed
no inhibitory effect on S. aurantiacum strains using crude
phenazine extracts with unknown concentrations. The authors
hypothesized that S. aurantiacum might be able to modify
and inactivate phenazine molecules through a detoxification
mechanism. However, it is also possible that the pyocyanin
concentration of their crude extract was out of the range
investigated in the present study (<12.5 µg/ml). In contrast to
our results, 10 mM (∼2.1 mg/ml) commercial pyocyanin had no
effect on S. aurantiacum strains in the study of Kaur et al. (2015).
This might be attributed to the differences of the techniques
applied. While Kaur et al. (2015) used the disk inhibition assay
on solid SCFM, we applied the broth microdilution test in RPMI-
1640 (the density of SCFM does not allow its use in the broth
microdilution assay).
Pseudomonal Nitrogen- and
Sulfur-Containing VOCs Stimulate the
Growth of Scedosporium spp.
Microbial VOCs serve as important mediators of intra- and
interspecies long-distance communication. These molecules
enable the producers to repel or inhibit the competitor organisms
and attract or enhance the growth of the mutualistic ones
(Effmert et al., 2012; Schulz-Bohm et al., 2017). For instance,
soil and plant-associated bacteria are reported to produce VOCs
having antifungal activity on common phytopathogenic fungi
(Cordero et al., 2014; Chaves-López et al., 2015; Ossowicki et al.,
2017). Moreover, certain microbial VOCs proved to possess plant
growth promoting effects, as well. Because of these favorable
properties, VOC-producing microorganisms are considered to be
promising biocontrol agents in the future (Schulz-Bohm et al.,
2017). On the other hand, VOCs may have a connection to
human health issues, as well. For instance, they are believed to
be appropriate biomarkers of human microbial infections and
serve as an alternative, non-invasive way for diagnosis (Lawal
et al., 2018). Besides, it is also suspected that volatile compounds
have an important role among the members of the normal human
microflora and the (co)infecting microbes during pathogenesis,
but this field is still not fully discovered. When Briard et al.
(2016) investigated the in vitro interactions of the two most
common CF pathogens, they revealed for the first time that
P. aeruginosa and other Gram-negative bacteria (i.e., Escherichia
coli and Burkholderia cepacia) was able to stimulate fungal growth
from a distance. Similarly, the present study confirms firstly
this fungal growth stimulatory effect of volatiles produced by
P. aeruginosa on Scedosporium species.
Briard et al. (2016) identified dimethyl sulfide as the main
VOC responsible for this effect and observed that another sulfur-
containing VOC, dimethyl disulfide could also stimulate the
growth of A. fumigatus in the lack of sulfur, but it had no growth
stimulatory effects in sulfur-replete medium. Contrastingly, the
sulfur-containing VOCs (i.e., sulfur-methyl thioacetate, dimethyl
disulfide and dimethyl trisulfide) of another Pseudomonas
species, applied either alone or in combination affected negatively
the growth of phytopathogenic fungal strains (Ossowicki et al.,
2017). Furthermore, Chaves-López et al. (2015) identified a
volatile molecule produced by Bacillus sp., called 3-hydroxy-2-
butanone, that possess both stimulatory and inhibitory effect
depending on the targeted fungal species. Our study confirmed
the results of Briard et al. (2016) on sulfur-depleted media
and raised the possibility that beside sulfur, nitrogen-containing
VOCs might also have growth stimulatory effect on scedosporia.
To our knowledge, the effect of nitrogen-containing VOCs of
P. aeruginosa was not investigated before on the growth of
Scedosporium or Aspergillus species.
In vitro Effect of Antibacterial Agents and
Corticosteroids on Scedosporia
Our results regarding the direct fungal growth-influencing effect
of corticosteroids seem to be controversial, especially considering
the previous study of Ng et al. (1994), who exposed Aspergillus
conidia to different doses of hydrocortisone and examined
their germination rate. The authors detected the species-specific
growth-promoting effect of this compound and reported 40%
increase in the growth rate of A. fumigatus in the presence
of 10−6 M hydrocortisone, while the growth of A. flavus,
A. niger and A. oryzae proved to be unaffected by the same
concentration. This latter observation might explain our results
as well, namely that corticosteroids had an opposite effect on the
growth of Scedosporium and A. fumigatus isolates. The results
of Ng et al. (1994) have not yet been confirmed by clinical
studies. Sudfeld et al. (2010) noted that inhaled corticosteroids
surprisingly decreased the likelihood of a fungal infection, which
is roughly in line with our in vitro data. While, Blyth et al.
(2010) found no correlation between corticosteroid therapy and
Scedosporium colonization.
Clinical studies revealed that a prior antibacterial therapy in
CF patients might be a risk factor for fungal infections (Burns
et al., 1999; Blyth et al., 2010). Nonetheless, this is the first
study that investigated the direct effect of antibacterial agents
on the growth of scedosporia. Our in vitro data are comparable
to previous clinical studies. Sudfeld et al. (2010) suggested
chronic oral antibiotics as one of the main risk factors for
filamentous fungal infections of CF patients. In the same work,
the administration of inhaled tobramycin did not increase the
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incidence of fungal isolation. These data suggest that tobramycin
might possess a dose-dependent effect on fungi. We assume,
that inhaled tobramycin results in a much higher drug level
in the lung tissues or in the sputum of CF patients than the
oral route, and these high drug concentrations might affect
fungal growth negatively as it was previously demonstrated
in vitro against Fusarium and Aspergillus spp., while its lower
concentrations might possess fungal growth-promoting effect
(Day et al., 2009; Shrestha et al., 2015). However, this hypothesis
contradicts with the study of Burns et al. (1999), who observed
an increased isolation of C. albicans and Aspergillus species in
the group treated with inhaled tobramycin compared with the
placebo group. Furthermore, Blyth et al. (2010) reported that
antistaphylococcal penicillins, such as flucloxacillin increased
the risk for Scedosporium colonization, but it was not affected
significantly by aminoglycosides (e.g., tobramycin).
CONCLUSION
As all in vitro tests do, our microbial interaction assays simplify
the environmental conditions, and thus, cannot completely
simulate all in vivo parameters, partly, because it is hard
to reconstruct such a complex environment as a CF lung
and partly, because probably not all the important factors
are known by now (Kerr, 1999). For example, one of such
factors can be the humidity, which may have indirect effect
on fungal growth by influencing the functionality of the
mucociliary clearance (Williams et al., 1996). Regarding the
plate-in-plate tests, it is noteworthy that metabolomes are time-
dependent and conditional. Furthermore, it might be strain-
specific and can be modulated by the environmental conditions,
e.g., nutrition availability, interactions with other species, etc.
(Bean et al., 2016; Neerincx et al., 2016). Therefore, the real-
life interactions between the investigated pathogens are probably
far more complicated with the presence of the normal microbial
communities and the wide range of host factors, as it was
experienced in the in vitro experimental conditions we used
in this study. That is why, we would like to consider in vivo
methods to investigate the pathogen–pathogen interactions and
to test the influence of a prior corticosteroid or antibacterial
therapy (e.g., tobramycin or flucloxacillin) on Scedosporium
infections in the future.
In conclusion, we confirmed that P. aeruginosa inhibited
the fungal growth in direct contact with Scedosporium species
and A. fumigatus. Besides, we observed that without any
physical contact, P. aeruginosa was able to enhance the growth
of scedosporia via VOCs. However, this growth-promoting
effect turned out to be species-specific and depended on the
availability of nutrients in the environment: major differences
were observed between S. aurantiacum and the members of
the S. apiospermum species complex on sulfur- and nitrogen-
depleted media. Our results suggest, that both antibacterial
agents and corticosteroids might affect the growth properties
of filamentous fungi underlying the importance of a carefully
selected therapy for patients with CF.
DATA AVAILABILITY
All datasets generated for this study are included in the
manuscript and/or the Supplementary Files.
AUTHOR CONTRIBUTIONS
TP and CV contributed to the design and implementation
of the research, and participated in drafting the manuscript.
GN and ET contributed to analyze the results and helped in
drafting the manuscript. CS and ET helped in the microscopic
and spectrophotometric analyses. MH and AS performed the
interaction and the microdilution tests, conducted statistical
analyses, designed the figures and the tables and drafted the
manuscript. All authors read and approved the final manuscript.
FUNDING
This study was supported by the “Lendület” grant of the
Hungarian Academy of Sciences (LP2016-8/2016), the project
GINOP-2.3.2-15-2016-00035 and the Hungary grant 20391-
3/2018/FEKUSTRAT of the Ministry of Human Capacities.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fmicb.
2019.00441/full#supplementary-material
REFERENCES
Bean, H. D., Rees, C. A., and Hill, J. E. (2016). Comparative analysis of the
volatile metabolomes of Pseudomonas aeruginosa clinical isolates. J. Breath Res.
10:047102. doi: 10.1088/1752-7155/10/4/047102
Blyth, C. C., Middleton, P. G., Harun, A., Sorrell, T. C., Meyer, W., and Chen, S. C.
(2010). Clinical associations and prevalence of Scedosporium spp. in Australian
cystic fibrosis patients: identification of novel risk factors? Med. Mycol. 48,
S37–S44. doi: 10.3109/13693786.2010.500627
Bodey, G. P., Vallejos, C., and Stewart, D. (1972). Flucloxacillin: a new
semisynthetic isoxazolyl penicillin. Clin. Pharmacol. Ther. 13, 512–515.
doi: 10.1002/cpt1972134512
Boon, C., Deng, Y., Wang, L. H., He, Y., Xu, J. L., Fan, Y., et al. (2008). A novel
DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans
morphological transition. ISME J. 2, 27–36. doi: 10.1038/ismej.2007.76
Bos, L. D., Sterk, P. J., and Schultz, M. J. (2013). Volatile metabolites of pathogens: a
systematic review. PLoS Pathog. 9:e1003311. doi: 10.1371/journal.ppat.1003311
Briard, B., Bomme, P., Lechner, B. E., Mislin, G. L., Lair, V., Prévost, M. C., et al.
(2015). Pseudomonas aeruginosa manipulates redox and iron homeostasis of
its microbiota partner Aspergillus fumigatus via phenazines. Sci. Rep. 5:8220.
doi: 10.1038/srep08220
Briard, B., Heddergott, C., and Latgé, J. (2016). Volatile compounds emitted by
Pseudomonas aeruginosa stimulate growth of the fungal pathogen Aspergillus
fumigatus. mBio 7:e00219-16. doi: 10.1128/mBio.00219-16
Frontiers in Microbiology | www.frontiersin.org 13 March 2019 | Volume 10 | Article 441
fmicb-10-00441 March 4, 2019 Time: 17:6 # 14
Homa et al. Inter-Kingdom Interactions Between CF Pathogens
Burns, J. L., Van Dalfsen, J. M., Shawar, R. M., Otto, K. L., Garber, R. L., Quan,
J. M., et al. (1999). Effect of chronic intermittent administration of inhaled
tobramycin on respiratory microbial flora in patients with cystic fibrosis.
J. Infect. Dis. 179, 1190–1196. doi: 10.1086/314727
Chaves-López, C., Serio, A., Gianotti, A., Sacchetti, G., Ndagijimana, M.,
Ciccarone, C., et al. (2015). Diversity of food-borne Bacillus volatile compounds
and influence on fungal growth. J. Appl. Microbiol. 119, 487–499. doi: 10.1111/
jam.12847
Chen, S. C., Patel, S., Meyer, W., Chapman, B., Yu, H., Byth, K., et al.
(2018). Pseudomonas aeruginosa inhibits the growth of Scedosporium and
Lomentospora in vitro. Mycopathologia 183, 251–261. doi: 10.1007/s11046-017-
0140-x
Cordero, P., Príncipe, A., Jofré, E., Mori, G., and Fischer, S. (2014). Inhibition
of the phytopathogenic fungus Fusarium proliferatum by volatile compounds
produced by Pseudomonas. Arch. Microbiol. 196, 803–809. doi: 10.1007/s00203-
014-1019-6
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C.,
Knudsen, T., et al. (2008). Infections caused by Scedosporium spp. Clin.
Microbiol. Rev. 21, 157–197. doi: 10.1128/CMR.00039-07
Day, S., Lalitha, P., Haug, S., Fothergill, A. W., Cevallos, V., Vijayakumar, R.,
et al. (2009). Activity of antibiotics against Fusarium and Aspergillus. Br. J.
Ophthalmol. 93, 116–119. doi: 10.1136/bjo.2008.142364
Denning, G. M., Wollenweber, L. A., Railsback, M. A., Cox, C. D., Stoll, L. L.,
and Britigan, B. E. (1998). Pseudomonas pyocyanin increases interleukin-8
expression by human airway epithelial cells. Infect. Immun. 66, 5777–5784.
Effmert, U., Kalderás, J., Warnke, R., and Piechulla, B. (2012). Volatile mediated
interactions between bacteria and fungi in the soil. J. Chem. Ecol. 38, 665–703.
doi: 10.1007/s10886-012-0135-5
Guarro, J., Kantarcioglu, A. S., Horré, R., Rodriguez-Tudela, J. L., Cuenca
Estrella, M., Berenguer, J., et al. (2006). Scedosporium apiospermum: changing
clinical spectrum of a therapy-refractory opportunist. Med. Mycol. 44, 295–327.
doi: 10.1080/13693780600752507
Hawksworth, D. L., Crous, P. W., Redhead, S. A., Reynolds, D. R., Samson, R. A.,
Seifert, K. A., et al. (2011). The Amsterdam declaration on fungal nomenclature.
IMA Fungus 2, 105–112. doi: 10.5598/imafungus.2011.02.01.14
Heatley, N. G. (1947). A simple plate method for multiple tests of the antibacterial
activity of many bacteria against other bacterial strains. Microbiology 1, 168–
170. doi: 10.1099/00221287-1-2-168
Hubert, D., Le Roux, E., Lavrut, T., Wallaert, B., Scheid, P., Manach, D., et al.
(2009). Continuous versus intermittent infusions of ceftazidime for treating
exacerbation of cystic fibrosis. Antimicrob. Agents Chemother. 53, 3650–3656.
doi: 10.1128/AAC.00174-09
Jennings, J. A., Courtney, H. S., and Haggard, W. O. (2012). Cis-2-decenoic acid
inhibits S. aureus growth and biofilm in vitro: a pilot study. Clin. Orthop. Relat.
Res. 470, 2663–2670. doi: 10.1007/s11999-012-2388-2
Kaur, J., Pethani, B. P., Kumar, S., Kim, M., Sunna, A., Kautto, L., et al. (2015).
Pseudomonas aeruginosa inhibits the growth of Scedosporium aurantiacum, an
opportunistic fungal pathogen isolated from the lungs of cystic fibrosis patients.
Front. Microbiol. 6:866. doi: 10.3389/fmicb.2015.00866
Kerr, J. R. (1999). Bacterial inhibition of fungal growth and pathogenicity. Microb.
Ecol. Health Dis. 11, 129–142. doi: 10.1080/089106099435709
Kerr, J. R., Taylor, G. W., Rutman, A., Høiby, N., Cole, P. J., and Wilson, R.
(1999). Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit
fungal growth. J. Clin. Pathol. 52, 385–387. doi: 10.1136/jcp.52.5.385
Kowacs, P. A., Soares Silvado, C. E., Monteiro de Almeida, S., Ramos, M., Abrão, K.,
and Madaloso, L. E. (2004). Infection of the CNS by Scedosporium apiospermum
after near drowning. Report of a fatal case and analysis of its confounding
factors. J. Clin. Pathol. 57, 205–207. doi: 10.1136/jcp.2003.8680
Kozlowska, J., Rivett, D. W., Vermeer, L. S., Carroll, M. P., Bruce, K. D., Mason,
A. J., et al. (2013). A relationship between Pseudomonal growth behaviour and
cystic fibrosis patient lung function identified in a metabolomic investigation.
Metabolomics 9, 1262–1273. doi: 10.1007/s11306-013-0538-5
Kravitz, J. N., Steed, L. L., and Judson, M. A. (2011). Intracavitary voriconazole for
the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary
mycetomas in fibrocystic sarcoidosis. Med. Mycol. 249, 198–201. doi: 10.3109/
13693786.2010.512619
Lackner, M., de Hoog, G. S., Yang, L., Moreno, L. F., Ahmed, A. S., Andreas, F., et al.
(2014). Proposed nomenclature for Pseudallescheria, Scedosporium and related
genera. Fungal Divers. 67, 1–10. doi: 10.1007/s13225-014-0295-4
Lawal, O., Knobel, H., Weda, H., Bos, L. D., Nijsen, T. M. E., Goodacre, R., et al.
(2018). Volatile organic compound signature from co-culture of lung epithelial
cell line with Pseudomonas aeruginosa. Analyst 143, 3148–3155. doi: 10.1039/
C8AN00759D
Lightly, T. J., Phung, R. R., Sorensen, J. L., and Cardona, S. T. (2017). Synthetic
cystic fibrosis sputum medium diminishes Burkholderia cenocepacia antifungal
activity against Aspergillus fumigatus independently of phenylacetic acid
production. Can. J. Microbiol. 63, 427–438. doi: 10.1139/cjm-2016-0705
LiPuma, J. J. (2010). The changing microbial epidemiology in cystic fibrosis. Clin.
Microbiol. Rev. 23, 299–323. doi: 10.1128/CMR.00068-09
Moriarty, T. F., McElnay, J. C., Elborn, J. S., and Tunney, M. M. (2007). Sputum
antibiotic concentrations: implications for treatment of cystic fibrosis lung
infection. Pediatr. Pulmonol. 42, 1008–1017. doi: 10.1002/ppul.20671
Mowat, E., Rajendran, R., Williams, C., McCulloch, E., Jones, B., Lang, S.,
et al. (2010). Pseudomonas aeruginosa and their small diffusible extracellular
molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol.
Lett. 313, 96–102. doi: 10.1111/j.1574-6968.2010.02130.x
Neerincx, A. H., Geurts, B. P., Habets, M. F., Booij, J. A., van Loon, J., Jansen,
J. J., et al. (2016). Identification of Pseudomonas aeruginosa and Aspergillus
fumigatus mono- and co-cultures based on volatile biomarker combinations.
J. Breath Res. 10:016002. doi: 10.1088/1752-7155/10/1/016002
Ng, T. T., Robson, G. D., and Denning, D. W. (1994). Hydrocortisone-enhanced
growth of Aspergillus spp.: implications for pathogenesis. Microbiology 140,
2475–2479. doi: 10.1099/13500872-140-9-2475
Noni, M., Katelari, A., Kapi, A., Stathi, A., Dimopoulos, G., and Doudounakis, S. E.
(2017). Scedosporium apiospermum complex in cystic fibrosis; should we treat?
Mycoses 60, 594–599. doi: 10.1111/myc.12634
O’Malley, Y. Q., Reszka, K. J., Rasmussen, G. T., Abdalla, M. Y., Denning, G. M.,
and Britigan, B. E. (2003). The Pseudomonas secretory product pyocyanin
inhibits catalase activity in human lung epithelial cells. Am. J. Physiol. Lung Cell.
Mol. Physiol. 285, L1077–L1086. doi: 10.1152/ajplung.00198.2003
O’Malley, Y. Q., Reszka, K. J., Spitz, D. R., Denning, G. M., and Britigan, B. E.
(2004). Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and
decreases its levels in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol.
Physiol. 287, L94–L103. doi: 10.1152/ajplung.00025.2004
Ossowicki, A., Jafra, S., and Garbeva, P. (2017). The antimicrobial volatile power of
the rhizospheric isolate Pseudomonas donghuensis P482. PLoS One 12:e0174362.
doi: 10.1371/journal.pone.0174362
Pethani, B. P. (2015). Involvement of Small Molecules in the Interaction
between Pseudomonas aeruginosa and Scedosporium aurantiacum. Ph.D. thesis,
Macquarie University, Sydney.
Pham, T., Giraud, S., Schuliar, G., Rougeron, A., and Bouchara, J. P. (2015).
Scedo-Select III: a new semi-selective culture medium for detection of
the Scedosporium apiospermum species complex. Med. Mycol. 53, 512–519.
doi: 10.1093/mmy/myv015
Ramirez-Garcia, A., Pellon, A., Rementeria, A., Buldain, I., Barreto-Bergter, E.,
Rollin-Pinheiro, R., et al. (2018). Scedosporium and Lomentospora: an updated
overview of underrated opportunists. Med. Mycol. 56, 102–125. doi: 10.1093/
mmy/myx113
Reece, E., Doyle, S., Greally, P., Renwick, J., and McClean, S. (2018). Aspergillus
fumigatus inhibits Pseudomonas aeruginosa in co-culture: implications of a
mutually antagonistic relationship on virulence and inflammation in the CF
airway. Front. Microbiol. 9:1205. doi: 10.3389/fmicb.2018.01205
Reece, E., Segurado, R., Jackson, A., McClean, S., Renwick, J., and Greally, P. (2017).
Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is
associated with poorer health in cystic fibrosis patients: an Irish registry
analysis. BMC Pulm. Med. 17:70. doi: 10.1186/s12890-017-0416-4
Reeslev, M., and Kjoller, A. (1995). Comparison of biomass dry weights and
radial growth rates of fungal colonies on media solidified with different gelling
compounds. Appl. Environ. Microbiol. 61, 4236–4239.
Rolfe, N. E., Haddad, T. J., and Wills, T. S. (2013). Management of Scedosporium
apiospermum in a pre- and post-lung transplant patient with cystic fibrosis.
Med. Mycol. Case Rep. 2, 37–39. doi: 10.1016/j.mmcr.2013.01.002
Frontiers in Microbiology | www.frontiersin.org 14 March 2019 | Volume 10 | Article 441
fmicb-10-00441 March 4, 2019 Time: 17:6 # 15
Homa et al. Inter-Kingdom Interactions Between CF Pathogens
Ryan, R. P., An, S. Q., Allan, J. H., McCarthy, Y., and Dow, J. M. (2015). The DSF
family of cell-cell signals: an expanding class of bacterial virulence regulators.
PLoS Pathog. 11:e1004986. doi: 10.1371/journal.ppat.1004986
Schulz-Bohm, K., Martín-Sánchez, L., and Garbeva, P. (2017). Microbial
volatiles: small molecules with an important role in intra- and inter-kingdom
interactions. Front. Microbiol. 8:2484. doi: 10.3389/fmicb.2017.02484
Schwarz, C., Brandt, C., Antweiler, E., Krannich, A., Staab, D., Schmitt-Grohé, S.,
et al. (2017). Prospective multicenter German study on pulmonary colonization
with Scedosporium /Lomentospora species in cystic fibrosis: epidemiology and
new association factors. PLoS One 12:e0171485. doi: 10.1371/journal.pone.
0171485
Sedlacek, L., Graf, B., Schwarz, C., Albert, F., Peter, S., Würstl, B., et al. (2015).
Prevalence of Scedosporium species and Lomentospora prolificans in patients
with cystic fibrosis in a multicenter trial by use of a selective medium. J. Cyst.
Fibros. 14, 237–241. doi: 10.1016/j.jcf.2014.12.014
Shrestha, S. K., Fosso, M. Y., Green, K. D., and Garneau-Tsodikova, S. (2015).
Amphiphilic tobramycin analogues as antibacterial and antifungal agents.
Antimicrob. Agents Chemother. 59, 4861–4869. doi: 10.1128/AAC.00229-15
Sibley, C. D., and Surette, M. G. (2011). The polymicrobial nature of airway
infections in cystic fibrosis: cangene gold medal lecture. Can. J. Microbiol. 57,
69–77. doi: 10.1139/w10-105
Sudfeld, C. R., Dasenbrook, E. C., Merz, W. G., Carroll, K. C., and Boyle,
M. P. (2010). Prevalence and risk factors for recovery of filamentous fungi in
individual with cystic fibrosis. J. Cyst. Fibros. 9, 110–116. doi: 10.1016/j.jcf.2009.
11.010
Sudhakar, T., and Karpagam, S. (2011). “Antifungal efficacy of pyocyanin produced
from bioindicators of nosocomial hazards,” in Proceedings of the International
Conference on Green Technology and Environmental Conservation (GTEC-
2011), (Piscataway, NJ: IEEE Xplore), 224–229. doi: 10.1109/GTEC.2011.
6167673
Sudhakar, T., Karpagam, S., and Shiyama, S. (2013). Antifungal efficacy of
pyocyanin produced from bioindicators of nosocomial hazards. Int. J. Chemtech
Res. 5, 1101–1106.
Sutherland, R., Croydon, E. A. P., and Rolinson, G. N. (1970). Flucloxacillin, a new
isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. Br.
Med. J. 4, 455–460. doi: 10.1136/bmj.4.5733.455
Tortorano, A. M., Richardson, M., Roilides, E., van Diepeningen, A., Caira, M.,
and Munoz, P. (2014). ESCMID and ECMM joint guidelines on diagnosis and
management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and
others. Clin. Microbiol. Infect. 20, 27–46. doi: 10.1111/1469-0691.12465
Twomey, K. B., O’Connell, O. J., McCarthy, Y., Dow, J. M., O’Toole, G. A., Plant,
B. J., et al. (2012). Bacterial cis-2-unsaturated fatty acids found in the cystic
fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa.
ISME J. 6, 939–950. doi: 10.1038/ismej.2011
Tyc, O., Song, C. X., Dickschat, J. S., Vos, M., and Garbeva, P. (2017). The ecological
role of volatile and soluble secondary metabolites produced by soil bacteria.
Trends Microbiol. 25, 280–292. doi: 10.1016/j.tim.2016.12.002
Usher, L. R., Lawson, R. A., Geary, I., Taylor, C. J., Bingle, C. D., Taylor, G. W.,
et al. (2002). Induction of neutrophil apoptosis by the Pseudomonas aeruginosa
exotoxin pyocyanin: a potential mechanism of persistent infection. J. Immunol.
168, 1861–1868. doi: 10.4049/jimmunol.168.4.1861
VandenBussche, H. L., and Homnick, D. N. (2012). Evaluation of serum
concentrations achieved with an empiric once-daily tobramycin dosage
regimen in children and adults with cystic fibrosis. J. Pediatr. Pharmacol. Ther.
17, 67–77. doi: 10.5863/1551-6776-17.1.67
Vinks, A. A., Brimicombe, R. W., Heijerman, H. G., and Bakker, W. (1997).
Continuous infusion of ceftazidime in cystic fibrosis patients during home
treatment: clinical outcome, microbiology and pharmacokinetics. J. Antimicrob.
Chemother. 40, 125–133. doi: 10.1093/jac/40.1.125
Wang, L. H., He, Y., Gao, Y., Wu, J. E., Dong, Y. H., He, C., et al. (2004).
A bacterial cell-cell communication signal with cross-kingdom structural
analogues. Mol. Microbiol. 51, 903–912. doi: 10.1046/j.1365-2958.2003.
03883.x
Wiederhold, N. P., and Lewis, R. E. (2009). Antifungal activity
against Scedosporium species and novel assays to assess antifungal
pharmacodynamics against filamentous fungi. Med. Mycol. 47, 422–432.
doi: 10.1080/13693780802510224
Williams, R., Rankin, N., Smith, T., Galler, D., and Seakins, P. (1996). Relationship
between the humidity and temperature of inspired gas and the function of
the airway mucosa. Crit. Care Med. 24, 1920–1929. doi: 10.1097/00003246-
199611000-00025
Wilson, R., Sykes, D. A., Watson, D., Rutman, A., Taylor, G. W., and Cole,
P. J. (1988). Measurement of Pseudomonas aeruginosa phenazine pigments
in sputum and assessment of their contribution to sputum sol toxicity for
respiratory epithelium. Infect. Immun. 56, 2515–2517.
Winstanley, C., and Fothergill, J. L. (2009). The role of quorum sensing in chronic
cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol. Lett. 290,
1–9. doi: 10.1111/j.1574-6968.2008.01394.x
Yabuuchi, E., and Ohyama, A. (1972). Characterization of “pyomelanin”-
producing strains of Pseudomonas aeruginosa. Int. J. Syst. Bacteriol. 22, 53–64.
doi: 10.1099/00207713-22-2-53
Zouhair, R., Rougeron, A., Razafimandimby, B., Kobi, A., Bouchara, J. P.,
and Giraud, S. (2013). Distribution of the different species of the
Pseudallescheria boydii/Scedosporium apiospermum complex in French patients
with cystic fibrosis. Med. Mycol. 51, 603–613. doi: 10.3109/13693786.2013.77
0606
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Homa, Sándor, Tóth, Szebenyi, Nagy, Vágvölgyi and Papp. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 15 March 2019 | Volume 10 | Article 441
